Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks

Here are 9 big pharma and big biotech cancer immunotherapy stocks.


9 Big Pharma and Biotech Cancer Immunotherapy Stocks

Name
& Monthly Returns

Symbol
& Snapshot

Recent Prices
& Trendline Chart

AmgenAMGN
AstraZenecaAZN
Bristol-Myers SquibbBMY
Gilead SciencesGILD
Incyte CorporationINCY
MerckMRK
Nektar TherapeuticsNKTR
NovartisNVS
PfizerPFE
Sparkline weekly price charts based on Alpha Vantage data.

9 Big Pharma and Biotech Cancer Immunotherapy Stocks

Name
& Last 100 Days Returns

Symbol

Last Close
& 100-Day Trendline Chart

AmgenAMGN$230.44
AstraZenecaAZN$55.55
Bristol-Myers SquibbBMY$70.53
Gilead SciencesGILD$62.32
Incyte CorporationINCY$68.83
MerckMRK$87.55
Nektar TherapeuticsNKTR$3.14
NovartisNVS$76.67
PfizerPFE$44.14


Portfolio Values

To inspect the performance of the Big Pharma and Biotech Cancer Immunotherapy Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

All 9 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,111.11 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of the $10,000 investment is $12,362. The percent return is 23.62%. The annualized return is 4.33%.


9 Big Pharma and Biotech Cancer Immunotherapy Stocks Returns

Name

Symbol

Monthly Returns & Details

AmgenAMGN52.36%
AstraZenecaAZN87.21%
Bristol-Myers SquibbBMY32.33%
Gilead SciencesGILD1.00%
Incyte CorporationINCY-39.22%
MerckMRK94.94%
Nektar TherapeuticsNKTR-86.97%
NovartisNVS11.59%
PfizerPFE59.34%


Portfolio Value Chart for Last 100 Daily Closes



Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Cancer Immunotherapy Stocks

Portfolio of Immune Checkpoint Inhibitor Stocks